β-CTx [ng/ml] AP [ng/ml]
  N Mean Mean ± 2SD Range Mean Mean ± 2SD Range
Patients without
malignant
disease 		110 0.4521 0.4521 ± 0.0564 0.11-1.21 134.43 134.43 ± 1.9728 117.0-150.0
Patients with
known breast
cancer without
bone metastasis 		30 0.893 0.893 ± 0.0554 0.58-1.2 129.1333 129.1333 ± 16.484 92.0-270.0
Patients with
known breast
cancer with bone metastasis 		50 75.382 75.382 ± 14.677 12.4-318 284.24 284.24 ± 31.2246 114.0-682.0
Table 1: Activity of β-CTx and AP [ng/ml] in the three different study groups Citation: Zulauf N, Marzi I, Oremek GM (2014) Prognostic Value of Bone Marker Beta-Crosslaps in Patients with Breast Carcinoma. J Mol Biomark Diagn 5: 193. doi:10.4172/2155-9929.1000193Page 3 of 5 J Mol